News

HC Wainwright & Co. Maintains Buy on Balchem, Lowers Price Target to $210

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Balchem (NASDAQ:BCPC) with a Buy and lowers the price target from $215 to $210.

Benzinga·03:40BCPC▼−1.1%

Balchem (BCPC) Stock Can Q3 Earnings Spark A Bigger Rerating?

The Q3 2026 release from Balchem landed with a clean headline. Record quarterly revenue of about US$291 million and adjusted earnings per share of US$1.57, both tied to stronger profitability, gave the report real substance. Yet the stock only moved about 2% higher on the day, a polite nod rather than a cheer. For an ingredients specialist that lives and dies on margin quality, that muted reaction sets up a clear question for investors: Is the market underplaying how much this quarter says...

Yahoo·05:11BCPC▼−1.1%

Balchem Corporation Q3 2026 Earnings Call Summary

Moby summary of Balchem Corporation's Q3 2026 earnings call

Yahoo·08:30BCPC▼−1.1%

Balchem: Record Sales, Great Fundamentals, Priced Fully, Hold

SeekingAlpha·06:16BCPC▼−1.1%

Balchem: 3 Key Takeaways for Long-Term Investors

Proprietary encapsulation tech is still penetrating its core markets, meaning growth can accelerate even without broader market expansion.

Yahoo·14:32BCPC▼−1.1%

Balchem (BCPC) Q3 2026 Earnings Call Transcript

Record results driven by specialty nutrients and better-for-you food trends.

Yahoo·14:13BCPC▼−1.1%

Balchem (NASDAQ:BCPC) Q3 2026 Results Meet Consensus With Broad Segment Growth and Strong Cash Flow

Balchem Q3 2026 results met estimates: EPS slightly beat, revenue just below consensus, with broad segment growth and strong cash flow.

ChartMill·08:22BCPC▼−1.1%

Balchem Q3 2026 Earnings Call Transcript

Balchem (NASDAQ:BCPC) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For

Benzinga·07:46BCPC▼−1.1%

Balchem Q3 Adj. EPS $1.57 Beats $1.53 Estimate, Sales $290.658M Beat $289.250M Estimate

Balchem (NASDAQ:BCPC) reported quarterly earnings of $1.57 per share which beat the analyst consensus estimate of $1.53 by 1.95 percent. This is a 16.3 percent increase over earnings of $1.35 per share from the same

Benzinga·03:01BCPC▼−1.1%

American Express, Eni On Deck Friday As Spending, Energy Demand Face Test

American Express headlines Friday’s reports, with premium-card spending and consumer resilience the central questions after a sharp year-to-date stock decline. Eni SpA, SLB, Infosys, First Citizens BancShares, Rogers

Benzinga·20:12

Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026

MONTVALE, N.J., Oct. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, October 23, 2026, at 11:00 AM Eastern Time (ET) to review third quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. Third quarter results will be published prior to the market opening on Friday, October 23, 2026. The press release, and its accompanying financial exhibits, will also be

Yahoo·07:00BCPC▼−1.1%

Vitamin K2 Market Forecasts Growth from $179.0M (2026) to $339.9M by 2031, Profiling Gnosis by Lesaffre, Balchem, J-OIL MILLS & Novonesis

The global Vitamin K2 market is projected to grow from USD 179.0 million in 2026 to USD 339.9 million by 2031, registering a 13.7% CAGR. Growth is driven by rising demand for bone and cardiovascular health supplements, preventive healthcare, functional nutrition, and clean-label ingredients. MK-7 is expected to dominate due to its high bioavailability, while pharmaceuticals offer significant growth potential. Asia Pacific will be the fastest-growing region, supported by aging populations and e-c

Yahoo·04:46BCPC▼−1.1%

Balchem (BCPC) Stock Looks Below Fair Value At Today’s Price

Balchem has delivered a 35.5% return over the past 3 years, which naturally prompts the question of whether the current share price is well supported by the cash the business can generate. With the stock recently closing at US$167.84, the gap between the recent share-price path and the underlying cash flows is what matters most for investors now. The 35.5% return over 3 years highlights the importance of assessing whether Balchem's current market value aligns with the cash it is expected to...

Yahoo·14:09BCPC▼−1.1%

Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026

MONTVALE, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference. About Balchem Corpor

Yahoo·07:00BCPC▼−1.1%